
Targeted Drug Selpercatinib Greatly Reduces Risk of Recurrence in Early-Stage Lung Cancer
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxOeVNEaVdMTzYyU3FPamJWVjJadlZPVWZld1IzVzRNcjhsMld2dW5YRVY4NzFQSnVEMWR2MGJRZFNIeWVmMWp6MzBVZVFPZHBreW5wMnB4aHlCTVZQNTdONGZFdXl2U1cxcGhtNm9ONXJrN2JIZDVwN3ZMQXBoUDNjUm8wNkF3SW5WX3RBQmJlbTlLTFZIYlhGdUlTOWlSMkVyeEluejBLUWhiT2t5Znc?oc=5" target="_blank">Targeted Drug Selpercatinib Greatly Reduces Risk of Recurrence in Early-Stage Lung Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Memorial Sloan Kettering Cancer Center</font>
